|RXi Pharmaceuticals Corporation -- USA Stock|| |
USD 0.56 0.0051 0.9%
IR Contact OfficerWe currently do not have informatin regarding Tamara McGrillen. This executive tanure with RXi Pharmaceuticals Corporation is not currenlty determined.
The company has return on total asset (ROA)
of (79.25) %
which means that it has lost $79.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (229.71) %
meaning that it created substantial loss on money invested by shareholders.
RXi Pharmaceuticals Corporationration, a clinicalstage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. RXi Pharmaceuticals Corporation (RXII) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 16 people. RXi Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.